Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:00 PM
Ignite Modification Date:
2025-12-24 @ 4:00 PM
NCT ID:
NCT02058966
Eligibility Criteria:
Inclusion Criteria:
* No history of pre-existing physical (including cardiovascular) illness
* No history of drug abuse or dependence
* Ability to read and write English
* Have had at least one exposure to a stimulant (e.g. cocaine, methamphetamine, ecstasy, methylphenidate or any medication in the stimulant class) in their lifetime
Exclusion Criteria:
* Pregnant
* Taking any psychotropic medication
* Meeting DSM-IV criteria for active substance abuse or dependence
* On any stimulant medication
* History or current hypertension (BP \> 140/90 mm Hg) or systolic hypotension (SBP \< 90 mm Hg)
* Subjects with resting pulse rate \> 90/min
* Any active medical illness
* Family history of abnormal heart rhythms, or sudden cardiac death
* Subjects who anticipate they may require the emergent use of epinephrine (such as an Epi-Pen®) for the treatment of severe allergic reactions
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT02058966
Study Brief:
Protocol Section:
NCT02058966